Skip to:Content
|
Bottom
Cover image for Development of sustainable bioprocesses : modeling and assessment
Title:
Development of sustainable bioprocesses : modeling and assessment
Personal Author:
Publication Information:
Chichester, England : John Wiley & Sons, 2006
Physical Description:
1v + 1 CD-ROM
ISBN:
9780470015599
General Note:
Accompanied by compact disc : CP 4822

Available:*

Library
Item Barcode
Call Number
Material Type
Item Category 1
Status
Searching...
30000010127053 TP248.3 H44 2006 Open Access Book Book
Searching...

On Order

Summary

Summary

Bioprocess technology involves the combination of living matter (whole organism or enzymes ) with nutrients under laboratory conditions to make a desired product within the pharmaceutical, food, cosmetics, biotechnology, fine chemicals and bulk chemicals sectors. Industry is under increasing pressure to develop new processes that are both environmentally friendly and cost-effective, and this can be achieved by taking a fresh look at process development; - namely by combining modern process modeling techniques with sustainability assessment methods.

Development of Sustainable Bioprocesses: Modeling and Assessment describes methodologies and supporting case studies for the evolution and implementation of sustainable bioprocesses. Practical and industry-focused, the book begins with an introduction to the bioprocess industries and development procedures. Bioprocesses and bioproducts are then introduced, together with a description of the unit operations involved. Modeling procedures, a key feature of the book, are covered in chapter 3 prior to an overview of the key sustainability assessment methods in use (environmental, economic and societal). The second part of the book is devoted to case studies, which cover the development of bioprocesses in the pharmaceutical, food, fine chemicals, cosmetics and bulk chemicals industries. Some selected case studies include: citric acid, biopolymers, antibiotics, biopharmaceuticals.

Supplementary material provides hands-on materials so that the techniques can be put into practice. These materials include a demo version of SuperPro Designer software (used in process engineering) and models of all featured case studies, excel sheets of assessment methods, Monte Carlo simulations and exercises.

Previously available on CD-ROM, the supplementary material can now be accessed via http://booksupport.wiley.com by entering the author name, book title or isbn and clicking on the desired entry. This will then give a listing of all the content available for download. Please read any text files before downloading material.


Author Notes

Professor Elmar Heinzle , Universität des Saarlandes, Germany

Dr. Charles Cooney , MIT, USA

Both internationally-recognised experts in biochemical engineering and modeling

Dr Arno Biwer , MIT/ Universität des Saarlandes, Germany


Table of Contents

Arnd Knoll and Jochen BuechsWilfried Storhas and Rolf MetzM. Abdul Kholiq and Elmar HeinzleDemetri PetridesElizabeth Zapalac and Karen McDonaldSindelia S. Freitas and Jose A. L. Santos and D. Miguel F. Prazeres
Prefacep. xiii
Acknowledgmentsp. xvii
List of Contributorsp. xix
Part I Theoretical Introduction
1 Introductionp. 3
1.1 Bioprocessesp. 3
1.1.1 History of Biotechnology and Today's Situationp. 3
1.1.2 Future Perspectivesp. 6
1.2 Modeling and Assessment in Process Developmentp. 7
2 Development of Bioprocessesp. 11
2.1 Types of Bioprocess and Bioproductp. 11
2.1.1 Biocatalysts and Process Typesp. 11
2.1.2 Raw Materialsp. 17
2.1.3 Bioproductsp. 20
2.2 Bioreaction Stoichiometry, Thermodynamics, and Kineticsp. 23
2.2.1 Stoichiometryp. 23
2.2.2 Thermodynamicsp. 28
2.2.3 Kineticsp. 29
2.3 Elements of Bioprocesses (Unit Operations and Unit Procedures)p. 32
2.3.1 Upstream Processingp. 33
2.3.2 Bioreactorp. 36
2.3.3 Downstream Processingp. 40
2.3.4 Waste Treatment, Reduction and Recyclingp. 50
2.4 The Development Processp. 52
2.4.1 Introductionp. 52
2.4.2 Development Steps and Participantsp. 53
3 Modeling and Simulation of Bioprocessesp. 61
3.1 Problem Structuring, Process Analysis, and Process Schemep. 62
3.1.1 Model Boundaries and General Structurep. 62
3.1.2 Modeling Stepsp. 63
3.2 Implementation and Simulationp. 66
3.2.1 Spreadsheet Modelp. 66
3.2.2 Modeling using a Process Simulatorp. 66
3.3 Uncertainty Analysisp. 71
3.3.1 Scenario Analysisp. 72
3.3.2 Sensitivity Analysisp. 73
3.3.3 Monte Carlo Simulationp. 75
4 Sustainability Assessmentp. 81
4.1 Sustainabilityp. 81
4.2 Economic Assessmentp. 82
4.2.1 Capital-Cost Estimationp. 83
4.2.2 Operating-Cost Estimationp. 88
4.2.3 Profitability Assessmentp. 94
4.3 Environmental Assessmentp. 95
4.3.1 Introductionp. 95
4.3.2 Structure of the Methodp. 96
4.3.3 Impact Categories and Groupsp. 99
4.3.4 Calculation of Environmental Factorsp. 103
4.3.5 Calculation of Indicesp. 105
4.3.6 Example Cleavage of Penicillin Gp. 105
4.4 Assessing Social Aspectsp. 107
4.4.1 Introductionp. 107
4.4.2 Indicators for Social Assessmentp. 108
4.5 Interactions between the Different Sustainability Dimensionsp. 112
Part II Bioprocess Case Studies
Introduction to Case Studiesp. 121
5 Citric Acid - Alternative Process using Starchp. 125
5.1 Introductionp. 125
5.2 Fermentation Modelp. 125
5.3 Process Modelp. 128
5.4 Inventory Analysisp. 130
5.5 Environmental Assessmentp. 132
5.6 Economic Assessmentp. 134
5.7 Conclusionsp. 135
6 Pyruvic Acid - Fermentation with Alternative Downstream Processesp. 137
6.1 Introductionp. 137
6.2 Fermentation Modelp. 137
6.3 Process Modelp. 138
6.3.1 Bioreaction and Upstreamp. 138
6.3.2 Downstream Processingp. 141
6.4 Inventory Analysisp. 142
6.5 Environmental Assessmentp. 144
6.6 Economic Assessmentp. 145
6.7 Conclusionsp. 145
7 L-Lysine - Coupling of Bioreaction and Process Modelp. 155
7.1 Introductionp. 155
7.2 Basic Strategyp. 156
7.3 Bioreaction Modelp. 156
7.4 Process Modelp. 159
7.5 Coupling of Bioreaction and Process Modelp. 162
7.5.1 Assumptionsp. 163
7.6 Results and Discussionp. 164
8 Riboflavin - Vitamin B[subscript 2]p. 169
8.1 Introductionp. 169
8.2 Biosynthesis and Fermentationp. 170
8.3 Production Process and Process Modelp. 171
8.3.1 Upstream Processingp. 172
8.3.2 Fermentationp. 174
8.3.3 Downstream Processingp. 174
8.4 Inventory Analysisp. 174
8.5 Ecological Assessmentp. 175
8.6 Economic Assessmentp. 176
8.7 Discussion and Concluding Remarksp. 177
9 [Alpha]Cyclodextrinp. 181
9.1 Introductionp. 181
9.2 Reaction Modelp. 182
9.3 Process Modelp. 182
9.3.1 Solvent Processp. 182
9.3.2 Non-solvent Processp. 184
9.4 Inventory Analysisp. 185
9.5 Environmental Assessmentp. 186
9.6 Economic Assessmentp. 186
9.7 Conclusionsp. 189
10 Penicillin Vp. 193
10.1 Introductionp. 193
10.2 Modeling Base Casep. 193
10.2.1 Fermentation Modelp. 193
10.2.2 Process Modelp. 194
10.3 Inventory Analysisp. 196
10.4 Environmental Assessmentp. 197
10.5 Economic Assessmentp. 197
10.6 Monte Carlo Simulationsp. 198
10.6.1 Objective Functions, Variables, and Probability Distributionsp. 198
10.6.2 Resultsp. 201
10.7 Conclusionsp. 206
11 Recombinant Human Serum Albuminp. 211
11.1 Introductionp. 211
11.2 Bioreaction Modelp. 212
11.2.1 Stoichiometryp. 212
11.2.2 Multi-stage Fermentation and Feeding Planp. 213
11.2.3 Total Broth Volume in Production Scale and Raw Material Consumptionp. 214
11.3 Process Modelp. 215
11.3.1 Bioreactionp. 215
11.3.2 Downstream Processingp. 215
11.4 Economic Assessmentp. 218
11.5 Ecological Assessmentp. 219
11.6 Conclusionsp. 221
12 Recombinant Human Insulinp. 225
12.1 Introductionp. 225
12.1.1 Two-chain Methodp. 226
12.1.2 Proinsulin Methodp. 226
12.2 Market Analysis and Design Basisp. 226
12.2.1 Process Descriptionp. 227
12.2.2 Inventory Analysis and Environmental Assessmentp. 233
12.2.3 Production Schedulingp. 234
12.3 Economic Assessmentp. 235
12.4 Throughput-Increase Optionsp. 237
12.5 Conclusionsp. 238
13 Monoclonal Antibodiesp. 241
13.1 Introductionp. 241
13.2 Process Modelp. 241
13.3 Inventory Analysisp. 243
13.4 Economic Assessmentp. 245
13.5 Environmental Assessmentp. 246
13.6 Uncertainty Analysisp. 247
13.6.1 Scenariosp. 247
13.6.2 Sensitivity Analysisp. 248
13.6.3 Monte Carlo Simulationsp. 249
13.7 Conclusionsp. 255
14 [Alpha]-1-Antitrypsin from Transgenic Plant Cell Suspension Culturesp. 261
14.1 Introductionp. 261
14.2 Process Descriptionp. 263
14.3 Model Descriptionp. 263
14.4 Discussionp. 265
14.5 Conclusionsp. 268
15 Plasmid DNAp. 271
15.1 Introductionp. 271
15.1.1 Generalp. 271
15.1.2 Case Introductionp. 272
15.1.3 Process Descriptionp. 272
15.2 Model Descriptionp. 275
15.2.1 Bioreaction Sectionp. 275
15.2.2 Downstream Sectionsp. 276
15.3 Inventory Analysisp. 277
15.4 Economic Assessmentp. 278
15.5 Environmental Assessmentp. 281
15.6 Discussionp. 282
15.7 Conclusionsp. 283
Indexp. 287
Go to:Top of Page